DCM Shriram Ltd

- The transcript does not mention any current or planned fundraising through debt or equity. - There is no specific discussion regarding new debt issuances or equity raises during the call or in the management comments. - The company highlights a strong balance sheet with net debt of Rs. 1,459 crore as of June 30, 2024, and healthy cash flows. - Management focuses on organic growth through capacity addition, technology, and new products without referring to external fundraising. - They continue to evaluate adjacencies and growth opportunities but have not disclosed any plans for raising funds via debt or equity.

- Commissioned 850 TPD caustic capacity in May 2024; capacity ramp-up will be gradual due to market oversupply. - 120 MW captive power plant commissioned in June 2024, improving cost efficiency. - Hydrogen peroxide plant started trial runs; expected to be commissioned in Q2 FY25. - Epichlorohydrin plant trials to start in Q2 FY25; commercial production expected early Q3 FY25. - Actively working on starting activities on epoxy and other chlorine downstream products; board evaluation ongoing. - Evaluating additional chlorine downstream opportunities to increase captive chlorine consumption beyond current ~55%. - Focus on capacity, capability, technology, new products, and value addition as part of growth strategy. - Sustainability and cost-efficiency improvements integrated into operations and strategic pathways.

- Chemicals Business: Optimistic about medium-term growth with capacity additions being absorbed comfortably due to steady demand across end-user industries (textiles, paper, alumina, etc.). - Caustic Soda: Expect steady volume growth domestically and in exports; aiming for significant capacity utilization by end of FY25 and optimal utilization by next year. - Chlorine Derivatives: Evaluating new downstream products to increase in-house consumption and expand revenue streams over next 2-4 years. - Epichlorohydrin: Ramp-up post-commissioning expected in Q3-Q4 FY25 with most revenue benefits anticipated in next financial year. - Shriram Farm Solutions: Maintaining double-digit topline growth driven by new product launches and R&D initiatives. - Fenesta Building Systems: Continued growth with expanded geographies and product SKUs; short-term impact due to elections expected to normalize. - Sugar & Ethanol: Pressure on margins but expanding ethanol volumes (15% YoY increase), with efforts to meet government blending targets enhancing growth prospects.

- Steady growth is expected driven by capacity expansion, capability enhancement, technology, new products, and value addition. - Chemicals and Vinyl businesses show improvement due to supportive cost environment and capacity additions, like the 850 TPD caustic capacity commissioned in May 2024. - Capacity ramp-up for new chemical capacities (caustic soda, epichlorohydrin, hydrogen peroxide) will be gradual due to short-term oversupply but positive medium-term outlook. - SFS (Shriram Farm Solutions) and Fenesta Building Systems businesses are growing and delivering consistent performance. - Energy cost reductions (e.g., renewable captive power plant) enhance cost efficiency. - Some margin pressures remain in sugar and ethanol due to increased costs not fully compensated by prices. - Overall, the company expects sustainable margins supported by operational efficiencies and expanding end-user industries. - Earnings growth will materialize as new plants stabilize, and capacity utilization improves, especially in the second half of FY25 and into FY26.

- Fenesta Building System has shown strong accretion in order booking as mentioned on page 7. - The business is expanding across geographies and SKUs despite the first quarter slowdown due to elections. - No specific numeric value for the current or expected order book or pending orders is disclosed in the transcript. - The general tone indicates a healthy pipeline of orders supporting growth momentum in the business segment.